NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / NYLI US LC R&D L
Total 13F shares
206,998
Share change
+8,061
Total reported value
$7,066,781
Price per share
$34.14
Number of holders
3
Value change
+$275,251
Number of buys
2
Number of sells
1

Institutional Holders of NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) as of Q4 2024

As of 31 Dec 2024, NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 206,998 shares. The largest 3 holders included NEW YORK LIFE INVESTMENT MANAGEMENT LLC, GTS SECURITIES LLC, and UBS Group AG. This page lists 3 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.